OCD symptoms. ACT+SSRIs, vs. Exposure and response prevention +SSRI, vs. continued SSRIs. N=40. Zemestani M, Salavati M, Seyedolshohadayi A, et al. (2022). A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Di

BibTeX

@article{allodium:a25c8ce43ca74619,
  title = {OCD symptoms. ACT+SSRIs, vs. Exposure and response prevention +SSRI, vs. continued SSRIs. N=40. Zemestani M, Salavati M, Seyedolshohadayi A, et al. (2022). A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Di},
  author = {Mehdi Zemestani and Mojgan Salavati and Asrin Seyedolshohadayi and Julie M. Petersen and Clarissa W. Ong and Michael P. Twohig and Ebrahim Ghaderi},
  year = {2020},
  journal = {ACBS},
  doi = {10.1177/0145445520982977},
  url = {https://doi.org/10.1177/0145445520982977}
}

RIS

TY  - JOUR
TI  - OCD symptoms. ACT+SSRIs, vs. Exposure and response prevention +SSRI, vs. continued SSRIs. N=40. Zemestani M, Salavati M, Seyedolshohadayi A, et al. (2022). A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Di
AU  - Zemestani, Mehdi
AU  - Salavati, Mojgan
AU  - Seyedolshohadayi, Asrin
AU  - Petersen, Julie M.
AU  - Ong, Clarissa W.
AU  - Twohig, Michael P.
AU  - Ghaderi, Ebrahim
PY  - 2020
PB  - ACBS
DO  - 10.1177/0145445520982977
UR  - https://doi.org/10.1177/0145445520982977
ER  - 

APA

Zemestani, M., Salavati, M., Seyedolshohadayi, A., Petersen, J. M., Ong, C. W., Twohig, M. P., & Ghaderi, E. (2020). OCD symptoms. ACT+SSRIs, vs. Exposure and response prevention +SSRI, vs. continued SSRIs. N=40. Zemestani M, Salavati M, Seyedolshohadayi A, et al. (2022). A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Di. ACBS. https://doi.org/10.1177/0145445520982977